Prostate Cancer Quiz

Quiz

Quiz: Costs and Health Care Resource Utilization in Patients With Metastatic, Castration-Resistant vs Nonmetastatic Prostate Cancer

05/02/2022

True or False: Compared with patients with nonmetastatic, hormone-sensitive prostate cancer (HSPC), overall annual out-of-pocket costs were higher for patients with metastatic, HSPC.

True or False: Compared with...

05/02/2022

Journal of Clinical Pathways

Sponsored

Quiz by Sanofi

Treatment Approaches in Metastatic Castration-Resistant Prostate Cancer

03/29/2022

Test your knowledge with this 5 question quiz exploring the treatment of patients with metastatic castration-resistant prostate cancer.

Test your knowledge with this 5...

03/29/2022

Journal of Clinical Pathways

Sponsored

QUIZ by Sanofi Genzyme

Quiz: Metastatic castration-resistant prostate cancer

02/11/2022

Test your knowledge with this 5 question quiz exploring the treatment of patients with metastatic castration-resistant prostate cancer.

Test your knowledge with this 5...

02/11/2022

Journal of Clinical Pathways

Quiz

Quiz: Overall Survival in Patients With Prostate Cancer Receiving Enzalutamide or Abiraterone

01/27/2022

True or False: Prostate-specific antigen progression at 4 weeks after enzalutamide or abiraterone is associated with shorter overall survival

True or False: Prostate-specific...

01/27/2022

Journal of Clinical Pathways

Quiz

Quiz: Managing Localized, Intermediate-Risk Prostate Cancer

05/05/2021

Journal of Clinical Pathways

Quiz

Quiz: Financial Burden of Contemporary Treatments for Prostate Cancer

02/08/2021

Journal of Clinical Pathways

Quiz

Quiz: Costs of Darolutamide for Castration-Resistant Prostate Cancer

12/12/2020

Journal of Clinical Pathways

Quiz

Quiz: Does Adjuvant Radiotherapy Improve EFS in Prostate Cancer?

11/25/2020

Journal of Clinical Pathways

Quiz

Quiz: Does Cabazitaxel Reduce Quality of Life in Metastatic Prostate Cancer?

10/09/2020

Journal of Clinical Pathways

Quiz

Quiz: Improving Event-Free Survival in Men With Prostate Cancer With Adjuvant Radiotherapy

10/02/2020

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Prostate Cancer Quiz

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products